Bafna Pharmaceuticals Ltd (BAFNAPHARM)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Bafna Pharmaceuticals Ltd (BAFNAPHARM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013107
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月27日
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Bafna Pharmaceuticals Ltd (Bafna Pharmaceuticals) is a pharmaceutical company which manufactures and markets pharmaceutical products. The company’s operations include domestic marketing, international marketing, international export and business development. Its products comprise raricap, raricap forte, raricap L suspension and raricap combi. Bafna Pharmaceuticals has instruments for research and development such as fluidised bed processor, retsch drier, RMG, bin blender, compression machine5 station, B tooling and 5 station D tooling, coating machine and blister alu semi automatic packing machine. The company supplies pharmaceutical formulations to regulated market of the UK and Australia, among others. Bafna Pharmaceuticals is headquartered in Chennai, Tamil Nadu, India.

Bafna Pharmaceuticals Ltd (BAFNAPHARM) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Bafna Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Bafna Pharmaceuticals Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Bafna Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Bafna Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Bafna Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Bafna Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
Bafna Pharma Completes Acquisition Of Raricap From Johnson & Johnson For US$4.6 Million 10
Asset Transactions 11
Strides Arcolab to Acquire 74% Stake in Branded Generics Unit of Bafna Pharma for USD8 Million 11
Acquisition 12
Mylan Rumored To Acquire Bafna Pharma 12
Bafna Pharmaceuticals Ltd – Key Competitors 13
Bafna Pharmaceuticals Ltd – Key Employees 14
Bafna Pharmaceuticals Ltd – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
Bafna Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Bafna Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Bafna Pharmaceuticals Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Bafna Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Bafna Pharmaceuticals Ltd, Deals By Therapy Area, 2011 to YTD 2017 8
Bafna Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Bafna Pharma Completes Acquisition Of Raricap From Johnson & Johnson For US$4.6 Million 10
Strides Arcolab to Acquire 74% Stake in Branded Generics Unit of Bafna Pharma for USD8 Million 11
Mylan Rumored To Acquire Bafna Pharma 12
Bafna Pharmaceuticals Ltd, Key Competitors 13
Bafna Pharmaceuticals Ltd, Key Employees 14
Bafna Pharmaceuticals Ltd, Subsidiaries 15

★海外企業調査レポート[Bafna Pharmaceuticals Ltd (BAFNAPHARM)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Nitori Holdings Co., Ltd.:戦略・SWOT・企業財務分析
    Nitori Holdings Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Nitori Holdings Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • CROS NT srl-製薬・医療分野:企業M&A・提携分析
    Summary CROS NT srl (CROS NT) is a contract research organization (CRO), which specializes in clinical data management, analysis, reporting and technologies. Its services include programming, analysis, medical writing, CROS academy training, methodology and clinical data management. Its outsourcing …
  • Salt River Project:企業の戦略・SWOT・財務分析
    Salt River Project - Strategy, SWOT and Corporate Finance Report Summary Salt River Project - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Spectral Medical Inc (EDT):医療機器:M&Aディール及び事業提携情報
    Summary Spectral Medical Inc (Spectral), formerly Spectral Diagnostics Inc, is a biotechnology company that develops and commercializes diagnostic solutions for patient management. The company’s products comprise EAA, toraymyxin and reagents, among others. Its EAA is an endotoxin activity assay, whi …
  • Regional Express Holdings Limited:企業の戦略・SWOT・財務情報
    Regional Express Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Regional Express Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Riemser Pharma GmbH-製薬・医療分野:企業M&A・提携分析
    Summary Riemser Pharma GmbH (Riemser), formerly Riemser Arzneimittel AG is a healthcare products provider that markets and sells lifecycle management products. The company offers analgesics, cardiovascular products, over-the-counter medicines, prescription drugs and dental products. Its products inc …
  • China Longyuan Power Group Corporation Ltd (916):電力:M&Aディール及び事業提携情報
    Summary China Longyuan Power Group Corporation Ltd (CLPGC), a subsidiary of China Energy Investment Corporation Ltd, carries out design, development, construction, management and operation of wind farms. It generates and sells electricity to the local grid companies. The company also operates other …
  • Skadden, Arps, Slate, Meagher & Flom LLP and Affiliates:企業の戦略・SWOT・財務情報
    Skadden, Arps, Slate, Meagher & Flom LLP and Affiliates - Strategy, SWOT and Corporate Finance Report Summary Skadden, Arps, Slate, Meagher & Flom LLP and Affiliates - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the compan …
  • Vectura Group Plc (VEC):製薬・医療:M&Aディール及び事業提携情報
    Summary Vectura Group Plc (Vectura) is a formulation and device business for inhaled airways products providing an integrated inhaled drug delivery platform. It develops inhalation products, to help patients suffering from airways diseases such as asthma, chronic obstructive pulmonary disease (COPD) …
  • Connecticut Municipal Electric Energy Cooperative:企業の戦略的SWOT分析
    Connecticut Municipal Electric Energy Cooperative - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competi …
  • Seelos Therapeutics, Inc. (SEEL):企業の財務・戦略的SWOT分析
    Seelos Therapeutics, Inc. (SEEL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Imperial Brands Plc:戦略・SWOT・企業財務分析
    Imperial Brands Plc - Strategy, SWOT and Corporate Finance Report Summary Imperial Brands Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Norwegian Energy Company ASA (NOR):石油・ガス:M&Aディール及び事業提携情報
    Summary Norwegian Energy Company ASA (Noreco) is an oil and gas company that offers exploration and development services. The company explores, produces and develops oil, gas, and natural gas liquids deposit properties. It operates through ongoing and planned exploration wells such as PL616 Haribo a …
  • Lee’s Pharmaceutical Holdings Ltd (950):企業の財務・戦略的SWOT分析
    Summary Lee's Pharmaceutical Holdings Ltd (Lee's Pharmaceutical) is a biopharmaceutical company that offers development of novel therapies and contract research services. The company provides products in the treatment of disease areas such as urology, cardiovascular oncology, dermatology, hematology …
  • Aptiv Plc. (APTV):企業の財務・戦略的SWOT分析
    Aptiv Plc. (APTV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Intuity Medical Inc:医療機器:M&Aディール及び事業提携情報
    Summary Intuity Medical Inc (Intuity Medical), formerly Rosedale Medical is a medical device company that designs and develops medical devices to monitor diabetes. The company offers products such as POGO, an automatic blood glucose monitoring system; and Patterns, a web based data management system …
  • NOV Inc (NOV):企業の財務・戦略的SWOT分析
    NOV Inc (NOV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Westinghouse Electric Company LLC-エネルギー分野:企業M&A・提携分析
    Summary Westinghouse Electric Company, LLC (Westinghouse), a subsidiary of Toshiba Corporation, is a nuclear energy company. It offers nuclear plant products, technologies, nuclear fuel, plant design and related services to utilities across the world. The company conducts the development, licensing, …
  • Cross Country Healthcare Inc (CCRN):企業の財務・戦略的SWOT分析
    Cross Country Healthcare Inc (CCRN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • MTAA Superannuation Fund:企業の戦略的SWOT分析
    MTAA Superannuation Fund - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆